AstraZeneca still waiting for FDA go-ahead to resume US trial | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Sunday
October 01, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SUNDAY, OCTOBER 01, 2023
AstraZeneca still waiting for FDA go-ahead to resume US trial

Coronavirus chronicle

Reuters
24 September, 2020, 04:10 pm
Last modified: 24 September, 2020, 04:11 pm

Related News

  • Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval
  • US FDA says India-made eye drop linked to some infections, blindness and one death
  • US FDA authorizes Novavax Covid vaccine for adults
  • US approves first pill for treatment of alopecia
  • US CDC backs full approval of Moderna's Covid-19 vaccine

AstraZeneca still waiting for FDA go-ahead to resume US trial

US Health and Human Services Secretary Alex Azar said on Wednesday the continued suspension showed the FDA was taking vaccine safety seriously

Reuters
24 September, 2020, 04:10 pm
Last modified: 24 September, 2020, 04:11 pm
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo

AstraZeneca is still waiting for the US drug regulator to approve the restart of the clinical trial of its potential Covid-19 vaccine in the United States almost three weeks after it was paused due to safety concerns.

The US trial of AstraZeneca's Covid-19 vaccine candidate, initially developed by the University of Oxford, remains on hold while regulators investigate an illness in one of the participants, even after a British study and other programmes outside of the United States have resumed.

"We are the sponsor of the US study. We then provided all this information to the FDA (US Food and Drug Administration) and we are waiting to hear their decision," Soriot told a virtual World Economic Forum discussion.

US Health and Human Services Secretary Alex Azar said on Wednesday the continued suspension showed the FDA was taking vaccine safety seriously.

A document posted online by Oxford university last week stated the illness in a British participant that triggered the pause on Sept. 6 may not have been associated with the vaccine.

Asked why the company had not disclosed details about the nature of the illness, Soriot said clinical trial regulators and independent supervisors were guarding participants' privacy.

Still, the company would look into increasing transparency without compromising individual rights and while also preventing the public and volunteers from drawing wrong conclusions, which could endanger trial enrollment.

"We are discussing with other companies as an industry what information we can offer without compromising patient privacy but also without compromising the trial itself," said the CEO.

Soriot also said that tests of the vaccine prototype on children had not started yet.

The British trial, launched in May seeking more than 12,000 volunteers, will have one out of 11 subgroups with children 5 to 12 years of age.

AstraZeneca Covid-19 Vaccine / US FDA

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Paperfly aborts flight
    Paperfly aborts flight
  • TBS sketch
    Visa curbs apply to those trying to gag media: Peter Haas
  • Obaidul Quader speaking at a peace and development rally arranged by the Dhaka District Awami League in Keraniganj this afternoon (26 September), protesting terrorism, militancy, anarchy, ill-politics and anti-state conspiracy of the BNP and Jamaat. Photo: Collected
    Why does BNP appeal for Khaleda's release to a govt they deem ‘illegal’: Quader

MOST VIEWED

  • BRACU, DU, JU, NSU lead Bangladeshi universities in World Rankings 2024
    BRACU, DU, JU, NSU lead Bangladeshi universities in World Rankings 2024
  • File photo of Rooppur Nuclear Power Plant/UNB
    First batch of uranium reaches Rooppur
  • Photo: BCB
    Shakib says he hasn't spoken with Litton since he broke his bat
  • Photo: Courtesy
    'No responsible captain could do that': Shakib directly blames Tamim for Afghanistan series loss
  • Khaleda Zia moved back to cabin from CCU
    Khaleda Zia moved back to cabin from CCU
  • BCL activist killed, 20 injured in AL-BNP clash in Chattogram
    BCL activist killed, 20 injured in AL-BNP clash in Chattogram

Related News

  • Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval
  • US FDA says India-made eye drop linked to some infections, blindness and one death
  • US FDA authorizes Novavax Covid vaccine for adults
  • US approves first pill for treatment of alopecia
  • US CDC backs full approval of Moderna's Covid-19 vaccine

Features

Photo & Coffee Sketch: Touseful Isalm

A coffee conversation with Rumi

15h | Features
Photo: Collected

The top 3 smartwatches of 2023: A glimpse into the future

20h | Brands
In the Nannu Market area in Mirpur 11, there are 35 such shops that provide clothes-fitting services like shortening of pants, tightening of sleeves and shirts, and so on. Photo: Noor-A-Alam

How former RMG workers reinvent themselves as fitting tailors

17h | Panorama
Photo: Collected

Almost 30 years later, Friends merch is still ‘perfection’

20h | Brands

More Videos from TBS

Shakib-Tamim: From best friends to bitter enemies

Shakib-Tamim: From best friends to bitter enemies

10h | TBS SPORTS
Many urban workers are moving to villages

Many urban workers are moving to villages

11h | TBS Stories
How China is reaping the benefits of war without adding fuel to the fire?

How China is reaping the benefits of war without adding fuel to the fire?

12h | TBS World
90% of beggars arrested abroad are of Pakistani origin

90% of beggars arrested abroad are of Pakistani origin

14h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]